(1) Routine inspections of pharmacies for compliance with KRS 217.815 to 217.826 shall be undertaken by the Kentucky Board of Pharmacy. (2) Every pharmacy shall retain for a period of two (2) years from July 15, 1982, a pharmacy record of all prescribed drug a nd biological products dispensed. The pharmacy record shall be retained for the purpose of providing valid data for bona fide research and reporting to the General Assembly as to the effectiveness of KRS 217.815 to 217.826. The pharmacy record shall include: (a) The brand name of the drug or biological product, when applicable. (b) The name of the manufacturer or the supplier of the drug or biological product, if the drug or biological product has no brand name. (c) The strength of the drug or biological product, when significant. (d) The quantity dispensed, when applicable. (e) The serial number of the prescription. (f) The date the prescription was originally dispensed and refilled. (g) The name of prescribing practitioner. (h) The name of patient for whom the drug or biological product was prescribed. (i) The price for which the drug or biological product was sold to the purchaser. (j) A notation if the practitioner indicated "Do not substitute" or the purchaser refused the product selected.
‹ Prev All Kentucky sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.